PLC Systems Discusses Benefits of CO2 TMR Therapy on CEOcast.com FRANKLIN, Mass., Oct. 30 /PRNewswire-FirstCall/ -- PLC Systems Inc. , the leader in carbon dioxide (CO2) TransMyocardial Revascularization (TMR) laser technology used to treat patients with severe angina, or heart pain, today announced that its President and Chief Executive Officer, Mark Tauscher, was interviewed by CEOcast.com on Wednesday, October 29, 2003. To listen to the interview, visit http://www.ceocast.com/. During the interview, PLC discusses the benefits the CO2 TMR angina relief therapy and reviews its third quarter financial results. PLC's third quarter results represent the sixth consecutive profitable quarter for the Company. PLC Systems Inc. is a medical device company specializing in the design and manufacturing of carbon dioxide (CO2) lasers and related disposable components to treat coronary artery disease. Edwards Lifesciences Corporation (NYSE:EW) is the exclusive U.S. marketer and distributor of PLC's CO2 Heart Laser 2 system, which a cardiac surgeon can utilize to perform CO2 transmyocardial revascularization (TMR). CO2 TMR, pioneered by PLC Systems, is a surgical technology for treating severe angina, or heart pain. The CO2 Heart Laser is the only revascularization laser that has published data showing long-term (five-year) angina relief in severely debilitated heart patients. For more information on PLC and its products, please visit the Company's Web site at http://www.plcmed.com/. CEOcast is the premier source of premier source of original and syndicated streaming broadcast interviews of Chief Executive Officers at public and private news-making companies. Organized by industry, its analysts average over 15 years experience covering and evaluating Wall Street's leading companies. CEOcast's programming is distributed to millions of on-line investors at over 700 financial web sites as well as to more than 20,000 portfolio managers, buy-side analysts and traders at more than 3,300 North American institutions. Content is also disseminated to over 7,000 investment research professionals representing over 425 institutions. All content is copyrighted to protect our licensing partners. Contact: John Jordan Director of Investor Relations 508-541-8800, ext. 145 DATASOURCE: PLC Systems Inc. CONTACT: John Jordan, Director of Investor Relations, PLC Systems Inc., +1-508-541-8800, ext. 145 Web site: http://www.plcmed.com/

Copyright